Diffuse leptomeningeal neuroepithelial tumor: 9 pediatric cases with chromosome 1p/19q deletion status and IDH1 (R132H) immunohistochemistry

American Journal of Surgical Pathology

Volumn 37, Issue 5, 2013, Pages 763-771

  Schniederjan, Matthew J ^a   Alghamdi, Sarah ^b   Castellano Sanchez, Amilcar ^b   Mazewski, Claire ^c   Brahma, Barunashish ^a   Brat, Daniel J ^c   Brathwaite, Carole D ^d   Janss, Anna J ^c  

^a Children's Healthcare of Atlanta ^*  (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

1p; 1p19q; disseminated; glioneuronal; leptomeninges; neurocytoma; neuroepithelial; oligodendroglioma; pediatric; spinal cord

Indexed keywords

IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; CARCINOMATOUS MENINGITIS; CHILD; CHROMOSOME 1; CHROMOSOME 19; CHROMOSOME DELETION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; NEUROEPITHELIOMA; PATHOLOGY; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; ISOCITRATE DEHYDROGENASE; MALE; MENINGEAL CARCINOMATOSIS; NEOPLASMS, NEUROEPITHELIAL; TUMOR MARKERS, BIOLOGICAL;

EID: 84876527927     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31827bf4cc     Document Type: Article

References (52)

1. McLaughlin JE. Juvenile astrocytomas with subarachnoid spread. J Pathol. 1976;118:101-107.
2. Civitello LA, Packer RJ, Rorke LB, et al. Leptomeningeal dissemination of low-grade gliomas in childhood. Neurology. 1988; 38:562-566.
3. Auer RN, Rice GP, Hinton GG, et al. Cerebellar astrocytoma with benign histology and malignant clinical course. Case report. J Neuro-surg. 1981;54:128-132.
4. Pollack IF, Hurtt M, Pang D, et al. Dissemination of low grade intracranial astrocytomas in children. Cancer. 1994;73:2869-2878.
5. McCowage G, Tien R, McLendon R, et al. Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide. Med Pediatr Oncol. 1996;27: 32-39.
6. Figueiredo EG, Matushita H, Machado AG, et al. Leptomeningeal dissemination of pilocytic astrocytoma at diagnosis in childhood: two cases report. Arq Neuropsiquiatr. 2003;61:842-847.
7. Bohner G, Masuhr F, Distl R, et al. Pilocytic astrocytoma presenting as primary diffuse leptomeningeal gliomatosis: report of a unique case and review of the literature. Acta Neuropathol. 2005;110: 306-311.
8. Gardiman MP, Fassan M, Orvieto E, et al. Diffuse leptomeningeal glioneuronal tumors: a new entity? Brain Pathol. 2010;20:361-366.
9. Huang T, Zimmerman RA, Perilongo G, et al. An unusual cystic appearance of disseminated low-grade gliomas. Neuroradiology. 2001;43:868-874.
10. Hervey-Jumper SL, Jumper M, Blaivas M, et al. Primary diffuse leptomeningeal oligodendroglioma. Pediatr Neurosurg. 2010;46: 326-328.
11. Bourne TD, Mandell JW, Matsumoto JA, et al. Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. Case report. J Neurosurg. 2006;105:465-469.
12. Rhiew RB, Manjila S, Lozen A, et al. Leptomeningeal dissemination of a pediatric neoplasm with 1p19q deletion showing mixed immunohistochemical features of an oligodendroglioma and neuro-cytoma. Acta Neurochir (Wien). 2010;152:1425-1429.
13. Rossi S, Rodriguez FJ, Mota RA, et al. Primary leptomenin-geal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child. Acta Neuropathol. 2009;118: 575-577.
14. Capper D, Zentgraf H, Balss J, et al. Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol. 2009;118:599-601.
15. Perilongo G, Gardiman M, Bisaglia L, et al. Spinal low-grade neoplasms with extensive leptomeningeal dissemination in children. Childs Nerv Syst. 2002;18:505-512.
16. Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astro-cytomas, and mixed oligoastrocytomas. J Clin Oncol. 2000;18: 636-645.
17. Yamamoto T, Komori T, Shibata N, et al. Multifocal neurocytoma/ gangliocytoma with extensive leptomeningeal dissemination in the brain and spinal cord. Am J Surg Pathol. 1996;20:363-370.
18. Perry A, Scheithauer BW, Macaulay RJ, et al. Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol. 2002;61: 947-955.
19. Vyberg M, Ulhoi BP, Teglbjaerg PS. Neuronal features of oligodendrogliomas-an ultrastructural and immunohistochemical study. Histopathology. 2007;50:887-896.
20. Beck DJ, Russell DS. Oligodendrogliomatosis of the cerebrospinal pathway. Brain. 1942;65:352-372.
21. Korein J, Feigin I, Shapiro MF. Oligodendrogliomatosis with intracranial hypertension. Neurology. 1957;7:589-594.
22. Best PV. Intracranial oligodendrogliomatosis. J Neurol Neurosurg Psychiatry. 1963;26:249-256.
23. Toso V. Metastatic diffusion to the leptomeninges. Acta Neurol (Napoli). 1967;22:366-376.
24. Pitt MA, Jones AW, Reeve RS, et al. Oligodendroglioma of the fourth ventricle with intracranial and spinal oligodendrogliomatosis: a case report. Br J Neurosurg. 1992;6:371-374.
25. Chen R, Macdonald DR, Ramsay DA. Primary diffuse leptome-ningeal oligodendroglioma. Case report. J Neurosurg. 1995;83: 724-728.
26. Ng HK, Poon WS. Diffuse leptomeningeal gliomatosis with oligodendroglioma. Pathology. 1999;31:59-63.
27. Gilmer-Hill HS, Ellis WG, Imbesi SG, et al. Spinal oligodendro-glioma with gliomatosis in a child. Case report. J Neurosurg. 2000;92:109-113.
28. Armao, et al. Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation. Am J Neuroradiol. 2000;21:1122-1126.
29. Stodberg T, Deniz Y, Esteitie N, et al. A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A. Neuropediatrics. 2002;33:266-270.
30. Psarros TG, Swift D, Mulne AF, et al. Neurocytoma-like neoplasm of the thoracic spine in a 15-month-old child presenting with diffuse leptomeningeal dissemination and communicating hydrocephalus. Case report. J Neurosurg. 2005;103:184-190.
31. Agamanolis DP, Katsetos CD, Klonk CJ, et al. An unusual form of superficially disseminated glioma in children: report of 3 cases. J Child Neurol. 2012;27:727-733.
32. Wharton SB, Chan KK, Hamilton FA, et al. Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study. Neuropathol Appl Neurobiol. 1998;24:302-308.
33. Wolf HK, Buslei R, Blumcke I, et al. Neural antigens in oligodendrogliomas and dysembryoplastic neuroepithelial tumors. Acta Neuropathol. 1997;94:436-443.
34. Katsetos CD, Del Valle L, Geddes JF, et al. Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status. J Neuropathol Exp Neurol. 2002;61:307-320.
35. Ng HK, Ko HCW, Tse CCH. Immunohistochemical and ultra-structural studies of oligodendrogliomas revealed features of neuro-nal differentition. Int J Surg Pathol. 1994;2:47-56.
36. Sarkar C, Roy S, Tandon PN. Oligodendroglial tumors. An immunohistochemical and electron microscopic study. Cancer. 1988;61:1862-1866.
37. Cruz-Sanchez FF, Rossi ML, Buller JR, et al. Oligodendrogliomas: a clinical, histological, immunocytochemical and lectin-binding study. Histopathology. 1991;19:361-367.
38. Blumcke I, Becker AJ, Normann S, et al. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells. J Neuropathol Exp Neurol. 2001;60:984-993.
39. Rodriguez FJ, Mota RA, Scheithauer BW, et al. Interphase Cyto-genetics for 1p19q and t(1;19)(q10;p10) may Distinguish Prognos-tically Relevant Subgroups in Extraventricular Neurocytoma. Brain Pathol. 2008;19:623-629.
40. Agarwal S, Sharma MC, Sarkar C, et al. Extraventricular neuro-cytomas: a morphological and histogenetic consideration. A study of six cases. Pathology. 2011;43:327-334.
41. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807-1812.
42. Hartmann C, Meyer J, Balss J, et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1, 010 diffuse gliomas. Acta Neuropathol. 2009;118:469-474.
43. Watanabe T, Nobusawa S, Kleihues P, et al. IDH1 mutations are early events in the development of astrocytomas and oligodendro-gliomas. Am J Pathol. 2009;174:1149-1153.
44. Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360:765-773.
45. Capper D, Weissert S, Balss J, et al. Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol. 2010;20:245-254.
46. Capper D, Reuss D, Schittenhelm J, et al. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta Neuropathol. 2011;121:241-252.
47. Suri V, Jha P, Agarwal S, et al. Molecular profile of oligoden-drogliomas in young patients. Neuro Oncol. 2011;13:1099-1106.
48. Giannini C, Burger PC, Berkey BA, et al. Anaplastic oligoden-droglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol. 2008;18:360-369.
49. Barbashina V, Salazar P, Holland EC, et al. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res. 2005;11:1119-1128.
50. Iwamoto FM, Nicolardi L, Demopoulos A, et al. Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas. J Neurooncol. 2008;88:293-298.
51. Kreiger PA, Okada Y, Simon S, et al. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas. Acta Neuropathol. 2005;109:387-392.
52. Rossi S, Rodriguez F, Dei Tos A, et al. Re: Diffuse leptomeningeal glioneuronal tumors: a new entity? Brain Pathol. 2009;19:745; author reply 746.